Bioactive anti-inflammatory antibacterial metformin-contained hydrogel dressing accelerating wound healing

Biomater Adv. 2022 Apr:135:212737. doi: 10.1016/j.bioadv.2022.212737. Epub 2022 Apr 22.

Abstract

Highly efficient wound healing and skin regeneration remain a challenge. Long-term inflammation and bacterial infection can inhibit the healing process and lead to the scar formation. Here, we report a hydrogel (FEM) formed by self-assembly of ε-poly-l-lysine-F127-ε-poly-l-lysine (EPL-F127-EPL) and metformin for wound repair. Especially, the role of metformin-based antibacterial hydrogel in wound healing and repair was investigated for the first time. FEM has inherent multifunctional properties, including controlled metformin release, anti-inflammatory and antibacterial activity, temperature responsiveness, injectable and self-healing capabilities. The in vivo results showed that FEM dressings accelerated the wound healing by stimulating the angiogenesis process of the wound tissue and anti-inflammation. This study shows that the multifunctional metformin-contained hydrogel scaffolds could enhance the wound repair through the anti-inflammation and accelerated angiogenesis, which could also expand the biomedical applications of metformin-based biomaterials.

Keywords: Anti-inflammation; Bioactive biomaterials; Metformin; Multifunctional scaffolds; Wound healing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Inflammatory Agents / pharmacology
  • Bandages
  • Hydrogels* / pharmacology
  • Metformin* / pharmacology
  • Polylysine
  • Wound Healing

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Hydrogels
  • Polylysine
  • Metformin